Annotation Detail for TTLL4

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of TTLL4 mRNA | increases expression | 20106945
|
C013038 |
hydroxyhydroquinone |
hydroxyhydroquinone results in increased expression of TTLL4 mRNA | increases expression | 17572062
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of TTLL4 mRNA | affects binding|increases activity|increases expression | 19710929
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of TTLL4 mRNA | affects expression | 19590694
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.58 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.11 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.42 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.63 | 17306315 16712894 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.57 | 19483382 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
2.01 | 16507464 17306315 15276417 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.46 | 18572023 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.54 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.54 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.74 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.74 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.57 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.90 | 12083418 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
9.01 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
9.01 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.70 | 12639820 12168785 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.31 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.76 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.55 | 19176532 19772884 18467677 16221962 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.52 | 12676792 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.58 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.21 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.24 | 15346721 12646999 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.87 | 16306350 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.70 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
6.70 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.08 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.89 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.89 | 16712894 15276417 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.42 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.90 | 15276417 16712894 17077188 17306315 19931552 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.07 | 16487513 19082730 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.07 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.27 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.25 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.51 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.51 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.22 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 18481113 19348381 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.38 | 12854658 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.53 | 15276417 17306315 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.59 | 12371664 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.24 | 16039940 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.55 | 19058328 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
2.85 | 19524636 18572023 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.10 | 12854658 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.63 | 11723127 16452187 16712894 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.16 | 11813266 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
5.06 | 17056641 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |